New York, NY (PRWEB) September 02, 2013
Bernstein Liebhard LLP notes an upcoming status conference in the federal Pradaxa lawsuit (http://www.pradaxalawsuithelp.com/) litigation currently underway in the U.S. District Court, Southern District of Illinois. The next Case Management Conference in the proceeding, which involves claims alleging the blood thinner’s potential to cause life-threatening internal bleeding side effects, is scheduled to take place on September 4th, 2013 at 9:30 a.m. According to a Case List update recently posted on the Court’s website, a total of 1,446 Pradaxa lawsuit claims have been filed in the federal litigation.* (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We are pleased to see this federal proceeding moving forward as we continue to hear from individuals who allegedly suffered the serious internal bleeding side effects associated with Pradaxa,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free case evaluations to patients who may have suffered injuries caused by Pradaxa.
The federal Pradaxa lawsuit litigation currently pending in Illinois is continuing to move forward. According to court documents, a Case Management Order issued on August 9th established some limitations addressing certain ex parte communications regarding claims filed in the proceeding, which has scheduled its first bellwether trial to start in September 2014.
Claims filed over the blood thinner manufactured by Boehringer-Ingelheim allege the company failed to warn consumers about the health risks associated with Pradaxa, a drug used to prevent strokes in patients with a heart-rhythm disorder known as atrial fibrillation. The lawsuits further allege that the company neglected to mention that since there is no readily available antidote to stop episodes of internal bleeding, side effects from the blood thinner may lead to death.
A recent article from Bloomberg.com reported that the drug was marketed as an improvement to warfarin, a medication that has been prescribed to people with this condition for decades.** Meanwhile, Pradaxa patients are continuing to file lawsuits alleging such side effects as cerebral hemorrhaging, gastrointestinal bleeding, and severe Pradaxa internal bleeding following a minor trauma. In the worst-case scenario, this injury may turn fatal due to the fact that there is no readily available antidote for Pradaxa, according to Bloomberg.com. By contrast, the administration of vitamin K has been used to stop hemorrhaging in those taking warfarin.
If you or a loved one suffered the life-threatening side effects associated with Pradaxa, you may be eligible to file a lawsuit seeking compensation for medical bills, lost wages, pain and suffering and other damages.Learn More about Pradaxa internal bleeding side effects by visiting Bernstein Liebhard LLP’s website. Call the Firm for a free and confidential case evaluation at 800-511-5092.
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com